These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35997807)

  • 1. De novo mutations in the BMP signaling pathway in lambdoid craniosynostosis.
    Timberlake AT; Kiziltug E; Jin SC; Nelson-Williams C; Loring E; ; Allocco A; Marlier A; Banka S; Stuart H; Passos-Buenos MR; Rosa R; Rogatto SR; Tonne E; Stiegler AL; Boggon TJ; Alperovich M; Steinbacher D; Staffenberg DA; Flores RL; Persing JA; Kahle KT; Lifton RP
    Hum Genet; 2023 Jan; 142(1):21-32. PubMed ID: 35997807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo mutations in inhibitors of Wnt, BMP, and Ras/ERK signaling pathways in non-syndromic midline craniosynostosis.
    Timberlake AT; Furey CG; Choi J; Nelson-Williams C; ; Loring E; Galm A; Kahle KT; Steinbacher DM; Larysz D; Persing JA; Lifton RP
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7341-E7347. PubMed ID: 28808027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in
    Timberlake AT; Jin SC; Nelson-Williams C; Wu R; Furey CG; Islam B; Haider S; Loring E; Galm A; ; Steinbacher DM; Larysz D; Staffenberg DA; Flores RL; Rodriguez ED; Boggon TJ; Persing JA; Lifton RP
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15116-15121. PubMed ID: 31292255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo variants implicate chromatin modification, transcriptional regulation, and retinoic acid signaling in syndromic craniosynostosis.
    Timberlake AT; McGee S; Allington G; Kiziltug E; Wolfe EM; Stiegler AL; Boggon TJ; Sanyoura M; Morrow M; Wenger TL; Fernandes EM; Caluseriu O; Persing JA; Jin SC; Lifton RP; Kahle KT; Kruszka P
    Am J Hum Genet; 2023 May; 110(5):846-862. PubMed ID: 37086723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gli3Xt-J/Xt-J mice exhibit lambdoid suture craniosynostosis which results from altered osteoprogenitor proliferation and differentiation.
    Rice DP; Connor EC; Veltmaat JM; Lana-Elola E; Veistinen L; Tanimoto Y; Bellusci S; Rice R
    Hum Mol Genet; 2010 Sep; 19(17):3457-67. PubMed ID: 20570969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two locus inheritance of non-syndromic midline craniosynostosis via rare
    Timberlake AT; Choi J; Zaidi S; Lu Q; Nelson-Williams C; Brooks ED; Bilguvar K; Tikhonova I; Mane S; Yang JF; Sawh-Martinez R; Persing S; Zellner EG; Loring E; Chuang C; Galm A; Hashim PW; Steinbacher DM; DiLuna ML; Duncan CC; Pelphrey KA; Zhao H; Persing JA; Lifton RP
    Elife; 2016 Sep; 5():. PubMed ID: 27606499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balanced translocation in a patient with craniosynostosis disrupts the SOX6 gene and an evolutionarily conserved non-transcribed region.
    Tagariello A; Heller R; Greven A; Kalscheuer VM; Molter T; Rauch A; Kress W; Winterpacht A
    J Med Genet; 2006 Jun; 43(6):534-40. PubMed ID: 16258006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of Smad-dependent BMP signaling in neural crest cells causes craniosynostosis in mice.
    Komatsu Y; Yu PB; Kamiya N; Pan H; Fukuda T; Scott GJ; Ray MK; Yamamura K; Mishina Y
    J Bone Miner Res; 2013 Jun; 28(6):1422-33. PubMed ID: 23281127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the molecular control of calvarial suture fusion in children with craniosynostosis.
    Coussens AK; Wilkinson CR; Hughes IP; Morris CP; van Daal A; Anderson PJ; Powell BC
    BMC Genomics; 2007 Dec; 8():458. PubMed ID: 18076769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXIN1 mutations in nonsyndromic craniosynostosis.
    Timberlake AT; Hemal K; Gustafson JA; Hao LT; Valenzuela I; Slavotinek A; Cunningham ML; Kahle KT; Lifton RP; Persing JA
    J Neurosurg Pediatr; 2024 Sep; 34(3):246-251. PubMed ID: 38905707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 1q22-q23.1 duplication in a patient with lambdoid and metopic craniosynostosis, muscular hypotonia, and psychomotor retardation.
    Sowińska-Seidler A; Olech EM; Socha M; Larysz D; Jamsheer A
    J Appl Genet; 2018 Aug; 59(3):281-289. PubMed ID: 29845577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing in syndromic craniosynostosis increases diagnostic yield and identifies candidate genes in osteogenic signaling pathways.
    Tønne E; Due-Tønnessen BJ; Vigeland MD; Amundsen SS; Ribarska T; Åsten PM; Sheng Y; Helseth E; Gilfillan GD; Mero IL; Heimdal KR
    Am J Med Genet A; 2022 May; 188(5):1464-1475. PubMed ID: 35080095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model.
    Kramer K; Yang J; Swanson WB; Hayano S; Toda M; Pan H; Kim JK; Krebsbach PH; Mishina Y
    Genesis; 2018 Jun; 56(6-7):e23220. PubMed ID: 30134066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice lacking the conserved transcription factor Grainyhead-like 3 (Grhl3) display increased apposition of the frontal and parietal bones during embryonic development.
    Goldie SJ; Arhatari BD; Anderson P; Auden A; Partridge DD; Jane SM; Dworkin S
    BMC Dev Biol; 2016 Oct; 16(1):37. PubMed ID: 27756203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development.
    Pan H; Zhang H; Abraham P; Komatsu Y; Lyons K; Kaartinen V; Mishina Y
    Dev Biol; 2017 Sep; 429(1):260-270. PubMed ID: 28641928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-occurrence of frameshift mutations in
    Timberlake AT; Wu R; Nelson-Williams C; Furey CG; Hildebrand KI; Elton SW; Wood JS; Persing JA; Lifton RP
    Hum Genome Var; 2018; 5():14. PubMed ID: 30038786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways.
    Takenouchi T; Sakamoto Y; Miwa T; Torii C; Kosaki R; Kishi K; Takahashi T; Kosaki K
    Am J Med Genet A; 2014 Nov; 164A(11):2869-72. PubMed ID: 25123707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected role of
    Calpena E; Wurmser M; McGowan SJ; Atique R; Bertola DR; Cunningham ML; Gustafson JA; Johnson D; Morton JEV; Passos-Bueno MR; Timberlake AT; Lifton RP; Wall SA; Twigg SRF; Maire P; Wilkie AOM
    J Med Genet; 2022 Feb; 59(2):165-169. PubMed ID: 33436522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling Mechanisms Underlying Genetic Pathophysiology of Craniosynostosis.
    Wu X; Gu Y
    Int J Biol Sci; 2019; 15(2):298-311. PubMed ID: 30745822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling.
    Kutkowska-Kaźmierczak A; Gos M; Obersztyn E
    J Appl Genet; 2018 May; 59(2):133-147. PubMed ID: 29392564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.